Frequency of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in 19 clinical isolates of Neisseria gonorrhoeae in Tokyo in 2002

Journal of Infection and Chemotherapy

Volumn 9, Issue 4, 2003, Pages 310-313

  Abe, Hiroyuki ^a   Nishimura, Taiji ^a   Norose, Yoshihiko ^a   Aoto, Taiji ^a   Ohzuka, Hiroki ^b   Ohkuni, Hisashi ^b  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b Medica Japan Co Ltd   (Japan)

Author keywords

Fluoroquinolone; Mutations in GyrA and ParC; Neisseria gonorrhoeae; Proteins; Resistance

Indexed keywords

AMPICILLIN; CEFACLOR; CEFAZOLIN; CEFDITOREN; CEFOTAXIME; CEFOTIAM; CLINDAMYCIN; COTRIMOXAZOLE; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; FLOMOXEF; IMIPENEM; LEVOFLOXACIN; MEROPENEM; MINOCYCLINE; PENICILLIN G; SPECTINOMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; CLINICAL ARTICLE; ENZYME SUBUNIT; GENE; GENE FREQUENCY; GENE MUTATION; GONOCOCCAL URETHRITIS; GYRA GENE; HUMAN; JAPAN; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; PARC GENE;

EID: 0346732987     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-003-0270-6     Document Type: Article

References (12)

1. Tanaka M, Takahashi K, Saika T, Kobayashi I, Ueno T, Kumazawa J. Development of fluoroquinolone resistance and mutation involving GyrA and ParC proteins among Neisseria gonorrhoeae isolates in Japan. J Urol 1998;159:2215-9.
2. Deguchi T, Yasuda M, Nakano M, Ozaki S, Ezaki T, Saito I, et al. Quinolone-resistant Neisseria gonorrhoeae: correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles. Antimicrob Agents Chemother 1996;40:1020-3.
3. Didomenico N, Link H, Knobel R, Caratsch T, Weschler W, Loewy ZG, et al. Cobas Amplicor: fully automated RNA and DNA amplification and detection system for routine diagnostic PCR. Clin Chem 1996;42:1915-23.
4. Welborn PP, Uyeda CT, Ellison-Birang N. Evaluation of Gonochek II as rapid identification system for pathogenic Neisseria species. J Clin Microbiol 1984;20:680-3.
5. Japan Society of Chemotherapy. The microdilution method. Chemotherapy 1990;38:103-5.
6. Lungu O, Sun XW, Wright Jr TC, Frenczy A, Richart RM, Silverstein S. A polymerase chain reaction-enzyme-linked immunosorbent assay method for detecting human papillomavirus in cervical carcinomas and high-grade cervical cancer precusors. Obstet Gynecol 1995;85:337-42.
7. Tanaka M. Antimicrobial resistant Neisseria gonorrhoeae. J Jpn Med Assoc 2001;126:1167.
8. Nishimura T. Panel discussion. "Gonoccocal urethritis and non-gonoccocal urethritis." 69th Japanese Urological Association Annual Meeting, Maebashi, Japan. 1981.
9. Japanese Society for Sexually Transmitted Diseases. 2001 Guideline for the diagnosis and treatment of sexually transmitted diseases. Gonococcal infection. Jpn J STD 2001;12:26-9.
10. Tanaka M, Nakayama H, Tonoe H, Egashira T, Kanayama A, Saika T, et al. A remarkable reduction in the susceptibility of Neisseria gonorrhoeae isolates to cephems and the selection of antibiotic regimens for the single-dose treatment of gonococcal infection in Japan. J Infect Chemother 2002;8:81-6.
11. Clendennen TE 3rd. Hames CS, Kees ES, Price FC, Rueppel WJ, Andrada AB, et al. In vitro antibiotic susceptibilities of Neisseria gonorrhoeae isolates in the Philippines. Antimicrob Agents Chemother 1992;36:277-82.
12. Onodera S. Fluoroquinolone-resistant gonococcus and cephem-resistant gonococcus. Rinsho Kensa 2001;45:827-32.